COVID-19 UPDATE: Click here for current news.
The Rx Consultant
 

Keeping health professionals current with useful, quick updates on drugs & therapy - with CE for pharmacists, pharmacy technicians and advanced practice RNs.

Your
Subscription to
The Rx Consultant
Includes:
  • Save Time  | 
  • Stay Current  | 
  • Get CE

Learn what's new with top-selling drugs and common health conditions, & get a quick review. Articles provide context and background in addition to the core information you will use every day.

Meet your state CE requirements and maintain/expand your expertise. 1-2 hours of CE in every issue. Always independently researched & written, with no drug industry money or bias.

Stay up-to-date on the news that matters most & always have answers to key questions at hand.

Quickly check your facts, verify a dose, or give a quick answer with our popular reference cards.

Get the top takeaways from every issue of The Rx Consultant - for an instant update or a quick refresher

Sharpen your patient counseling skills with expert answers to common questions & key counseling points.

Stay ahead of the curve with at-a-glance updates on drugs, doses, common side effects & interactions, indications, treatment guidelines, and more.

50+ hours of current CE on the topics pharmacists, nurse practitioners and pharmacy technicians need to stay current. Get the CE you need today.

 

We do the research, distill the results, consult the experts, and check every fact - so you don't have to.

 
Popular CE Programs
 

1.5  Hours of CE for Pharmacists Advanced Practice RNs & Pharmacy Technicians.

1.5 Hours of ACPE approved CE. Pharmacists, Advanced Practice RNs & Pharmacy Technicians.

1.5 Hours of ACPE approved CE. Pharmacists, Advanced Practice RNs & Pharmacy Technicians.

Our Clients
"The Rx Consultant definitely saves me time. It has the information I need in an easy-to-read format." - W.Gardner
  • Prescribing Controlled Substances Via Telemedicine
    To limit exposure to Covid-19, the DEA is allowing health care providers to prescribe controlled ... Read More
  • CDC Vaccine Schedule is Not Followed for Many Children
    The CDC Advisory Committee on Immunization Practices (ACIP) recommends 14 different vaccinations... Read More
  • Statin Benefits in the Elderly
    Statins are the most commonly used medications for lowering LDL cholesterol – preventing cardiov... Read More
  • New Triple Antibiotic
    Addressing antibiotic-resistant infections is a key public health challenge. The FDA has approve... Read More
  • Revisiting CBD Drug Interactions
    The May issue of The Rx Consultant focused on cannabidiol (CBD) and included a brief summary of d... Read More
  • Statins May Lower Glaucoma Risk
    Statins have an established role in the prevention and treatment of cardiovascular (CV) disease.... Read More
  • Heart failure (HF) is a common condition that causes significant disability and death in the US and around the world. About 6.5 million adults in the US have HF – and despite advances in drug and device therapies, HF was a contributing cause of 1 in 8 deaths in 2017. The estimated total cost of HF (including health care, medication and missed work) in 2012 was almost $31 billion.The prevalence of HF continues to rise, and is expected to exceed 8 million people by 2030. By this time, the medical costs of HF management are projected to reach $53 billion annually.
  • There has been an increase in prescription medications, mainly stimulants, for the treatment of attention deficit hyperactivity disorder (ADHD) along with an explosion of new formulations. A 2016 CDC report estimates that about 9% of children 2 to 17 years of age (6.1 million) have been diagnosed with ADHD. Among the children with ADHD, 6 out of 10 were taking ADHD medication. The lifetime prevalence of ADHD has been estimated to be as high as 8.1%. In 2015, 4% of privately insured women ages 15 to 44 filled an ADHD prescription, most often for a stimulant such as mixed amphetamine salts or methylphenidate – a 344% increase compared to 2003.3 In 2016, the CDC reported that 3 out of 4 preschoolers diagnosed with ADHD were prescribed stimulants, despite a recommendation for behavior therapy alone for that age group.

    This issue is the first of a 2-part review of ADHD. Part 1 focuses on stimulant and nonstimulant treatments for ADHD, including the advantages of certain formulations and delivery methods, common and serious adverse effects, and possible longterm effects. Part 2 is available online at rxconsultant.com and summarizes diagnosis and clinical presentation in all age groups (including adults), non-drug and behavioral interventions, clinically significant drug interactions with stimulants and nonstimulants, and the comorbid conditions that often accompany ADHD.


  • This issue highlights the use of continuous glucose monitoring (CGM) systems, sodium glucose transport protein-2 (SGLT2) inhibitors, newer insulin formulations, and the expert guideline recommendations focused on individualization of therapy.

    In 2017, the Centers for Disease Control reported that over 30 million people in the US (~10% of the population) have diabetes, including 7.2 million who are undiagnosed. The total estimated cost of diagnosed diabetes in the US was $327 billion in 2017.2 Individuals with diabetes incur average annual medical expenses of about $16,750 – more than twice the expense for people without diabetes.

    Over the last decade, the options for managing diabetes have grown dramatically – including new medication classes (eg, glucagon- like peptide-1 agonists, sodium-glucose transport protein-2 inhibitors), new insulin analogs (eg, insulin degludec, biosimilar insulins), and new technologies to help patients monitor their diabetes (eg, continuous glucose monitoring).

    Clinical practice guidelines have increased the emphasis on individualizing treatment options and goals to meet the needs of each patient. Patients have more say in the management of their diabetes and overall health. It is essential that healthcare providers help patients navigate the vast pool of information available at their fingertips. Diabetes patients can easily get confused by the often-conflicting information or misinformation available on television and the internet, and from friends and family members. Community providers need a good, working knowledge of patient-specific diabetes management, including current treatments and technologies...

 
ACPE logo

Pharmacists: Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Advanced Practice Nurses : (Nurse Practitioners and Clinical Nurse Specialists): CE hours provided by Continuing Education Network (in The Rx Consultant) meet the ANCC criteria and the AANP criteria for formally approved continuing education hours. Click here for more information about the ANCC criteria. Click here for more information about the AANP criteria.

Registered Nurses : Click here for specific information on acceptance of CE from The Rx Consultant by your state Board of Registered Nursing.